Is Long Covid a myth? – Spiked

So, it seems that Long Covid is not as widespread as we were told it was. More importantly – and, yes, this is the more difficult thing to discuss – maybe Long Covid is not as real as we were told it was, either. Maybe the fairly typical problems that a minority of people experience after a virus were, in this case, unjustifiably blown up into a whole new sickness. Alongside examining the measurable, physical prevalence of long-lasting symptoms in people who have been infected with Covid – something it is very important for society to do – we must also analyse the cultural components to Long Covid. How much did the culture of fear around Long Covid help to convince people that they had it? And did a broader culture of victimhood likewise help to coax people to self-identify as suffering from this new, seemingly fascinating ailment, and even to embrace Long Covid as a kind of identity?


With IFFIm, donors have an immediate impact – IFFIm

IFFIm’s financial base consists of grants from 10 sovereign sponsors. By signing the grant agreements, countries agree to pay these obligations in a specified schedule of payments.

CountryUS$ equivalentCurrency of pledge
United KingdomUS$ 3,652 million over 23 yearsGBP 2,130 million
France FranceUS$ 1,884 million over 20 yearsEUR 1,390 million
ItalyUS$ 821 million over 25 yearsEUR 654 million* *Includes a pledge to support the Coalition for Epidemic Preparedness Innovations (CEPI) through Gavi for the development of COVID-19 vaccine candidates.  
Norway NorwayUS$ 647 million over 25 yearsUS$ 27 million & NOK 5,100 million* *Includes additional pledges to support the Coalition for Epidemic Preparedness Innovations (CEPI) through Gavi for the development of COVID-19 vaccine candidates
The Netherlands The NetherlandsUS$ 487 million over 20 yearsEUR 330 million & US$ 67 million
AustraliaUS$ 284 million over 20 yearsAUD 288 million
Spain SpainUS$ 240 million over 20 yearsEUR 190 million
Sweden SwedenUS$ 38 million over 15 yearsSEK 276 million
South AfricaUS$ 20 million over 20 yearsUS$ 20 million
Brazil BrazilUS$ 20 million over 20 yearsUS$ 20 million
TOTALUS$ 8 billion (approximately)


We’ll Have Herd Immunity by April – Wall Street Journal

Amid the dire Covid warnings, one crucial fact has been largely ignored: Cases are down 77% over the past six weeks. If a medication slashed cases by 77%, we’d call it a miracle pill. Why is the number of cases plummeting much faster than experts predicted?

In large part because natural immunity from prior infection is far more common than can be measured by testing. Testing has been capturing only from 10% to 25% of infections, depending on when during the pandemic someone got the virus. Applying a time-weighted case capture average of 1 in 6.5 to the cumulative 28 million confirmed cases would mean about 55% of Americans have natural immunity.

…explained only by natural immunity. Behavior didn’t suddenly improve over the holidays; Americans traveled more over Christmas than they had since March. Vaccines also don’t explain the steep decline in January. Vaccination rates were low and they take weeks to kick in.


Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Randomised control trial study showing safety and efficacy of COVID-19 vaccine has clear conflicts of interest.

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine AZD1222

News Videos

Coronavirus: Hunger trumps fear in South Africa – Sky News